NAEJA Pharmaceutical Receives "Company of the Year" Award from Alberta Life Sciences Community

EDMONTON, Nov. 27, 2013 /CNW/ - NAEJA Pharmaceutical, Inc. was recognized with the "Company of the Year" award by BioAlberta, an industry association that supports the province's growing community of biotechnology, environmental science, medical devices, agriculture, bio-informatics and natural health product companies. The award was presented to NAEJA at the 14th Annual General Meeting and Awards Gala, an event that was attended by approximately 150 industry leaders and government dignitaries. This award recognizes life sciences companies that show significant achievement within Alberta's marketplace and business community through strong performance or a leadership role.

"We are honored to receive this prestigious award from BioAlberta, which serves as a testimony to the many contributions that NAEJA has made to the Alberta and Canadian biotechnology industry over the years.  In collaboration with global strategic partners both in industry as well as academia, our team of scientists has discovered and developed many life-saving drugs that are either in various stages of development or are in clinical use" remarked Christopher G. Micetich, chief executive officer of NAEJA Pharmaceutical. "NAEJA has also fostered an environment of scientific excellence and has been a major employer of graduates from universities across Canada and globally.  We look forward to continuing to make tangible contributions to the life sciences community here in Alberta and worldwide."

About NAEJA
NAEJA is a privately owned pharmaceutical drug discovery and development company headquartered in Edmonton, Alberta, Canada.  The company was established in 1987 (earlier known as SynPhar laboratories Inc.) and employs over 50 scientists, of whom 90% hold Ph.D. degrees.  NAEJA has an extensive track record of drug discovery and development in many disease areas including infectious diseases, inflammation, cancer, cardiovascular disease and diseases of the central nervous system.  NAEJA collaborates with major pharmaceutical and biotechnology companies worldwide.  For more information on the company, please visit www.NAEJA.com.

SOURCE: NAEJA Pharmaceutical Inc.

Dr. Sameeh M. Salama
NAEJA Pharmaceutical, Inc.
780-989-9826
[email protected]